Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial
- PMID: 33408027
- PMCID: PMC7779261
- DOI: 10.1016/j.ijantimicag.2020.106237
Response to effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial
Comment on
-
Effect estimation of hydroxychloroquine for COVID-19: a secondary analysis of an open label non-randomized clinical trial.Int J Antimicrob Agents. 2021 Jan;57(1):106172. doi: 10.1016/j.ijantimicag.2020.106172. Int J Antimicrob Agents. 2021. PMID: 33408017 Free PMC article. No abstract available.
References
-
- European Centre for Disease Prevention and Control. Guidance for discharge and ending isolation in the context of widespread community transmission of COVID-19 – first update. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidan... (Accessed 4 October, 2020)
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical